You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 85 No. 3, MARCH 1950 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (33)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

HYPERTHYROIDISM

Treatment with Radioactive lodine

SERGEI FEITELBERG, M.D.; PAUL S. KAUNITZ, M.D.; SOLOMON SILVER, M.D.; NORMAN SIMON, M.D.; LOUIS R. WASSERMAN, M.D.; STEPHEN BENNETT YOHALEM, M.D.

Arch Intern Med. 1950;85(3):471-478.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

THE THYROID gland has the ability to concentrate the isotopes of iodine, and this selective uptake is increased greatly in hyperplastic disease of the thyroid gland. Since the initial investigations by Hertz, Roberts and Evans,1 Hamilton and Soley2 and Hertz and others3 there have been numerous reports on the use of radioactive iodine (I130 and I131) in the treatment of patients with hyperthyroidism. The various investigators differ somewhat concerning dosage and the management of their patients, but the basic approach is the same. An initial calculated dose of radioactive iodine is administered orally to the patient, and the majority of investigators prescribe additional therapy as indicated by the subsequent course. Since we studied over 200 patients in the two and a half years previous to this report, we believe it worth while to record our experience.

MATERIAL

The data were sufficiently complete to justify conclusions . . . [Full Text PDF of this Article]


Author Affiliations

NEW YORK

From the Physics Department and the Medical Services, Mount Sinai Hospital. Dr. Kaunitx is Sara Welt Fellow; Dr. Simon is Dazian Fellow, and Dr. Yohalem is Elsa and William Menke Fellow.


Footnotes

The radioactive iodine (I131) was supplied on allocation by the United States Atomic Energy Commission.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1950 American Medical Association. All Rights Reserved.